CN Stock MarketDetailed Quotes
000153 Anhui Fengyuan Pharmaceutical
- 6.77
- -0.12-1.74%
Market Closed Dec 13 15:00 CST
3.15BMarket Cap19.18P/E (TTM)
6.94High6.76Low85.39KlotVolume6.85Open6.89Pre Close58.34MTurnover1.89%Turnover Ratio19.74P/E (Static)464.84MShares6.9752wk High1.58P/B3.07BFloat Cap4.1552wk Low7.58Limit Up452.94MShs Float13.89Historical High6.20Limit Down2.61%Amplitude1.11Historical Low0.11Dividend TTM6.83Avg Price49.83KlotAsk1.58%Div YieldTTM100Lot Size34.49KlotBid
Anhui Fengyuan Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -11.28%2.68B | -10.73%1.79B | -6.34%944.05M | -5.83%3.42B | -5.10%3.02B | -4.27%2B | 7.97%1.01B | 5.13%3.63B | 8.65%3.19B | 11.74%2.09B |
| Refunds of taxes and levies | -56.94%4.07M | -55.15%3.41M | -72.35%1.57M | -60.04%13.57M | -70.06%9.46M | -69.12%7.61M | -53.20%5.66M | 2.37%33.95M | 203.41%31.6M | 302.28%24.65M |
| Cash received relating to other operating activities | -17.75%94.77M | -11.37%61.76M | 52.07%31.85M | 89.55%384.65M | -27.48%115.22M | -39.71%69.68M | -59.72%20.95M | -6.20%202.92M | -4.85%158.88M | -13.16%115.58M |
| Cash inflows from operating activities | -11.65%2.78B | -10.92%1.85B | -5.52%977.47M | -1.30%3.82B | -6.76%3.15B | -6.82%2.08B | 3.70%1.03B | 4.44%3.87B | 8.57%3.38B | 10.98%2.23B |
| Goods services cash paid | -7.11%1.9B | -6.92%1.27B | -3.00%659.18M | -4.24%2.13B | -13.38%2.05B | -11.61%1.36B | 3.92%679.55M | 4.01%2.23B | 11.26%2.36B | 12.11%1.54B |
| Staff behalf paid | 4.44%311.12M | 4.14%214.03M | 6.62%124.53M | 6.54%420.33M | 12.04%297.89M | 8.84%205.52M | 8.13%116.8M | 10.69%394.51M | 9.59%265.88M | 13.08%188.83M |
| All taxes paid | -30.26%167.44M | -34.41%122.82M | -18.18%69.46M | 38.00%295.64M | 36.57%240.09M | 67.90%187.24M | 113.68%84.89M | -0.18%214.24M | 1.79%175.8M | -0.35%111.52M |
| Cash paid relating to other operating activities | -22.50%334.1M | -22.98%213.61M | -18.55%108.52M | 20.51%717.71M | -2.26%431.12M | -7.84%277.35M | -20.54%133.24M | -18.41%595.57M | -2.26%441.1M | 7.68%300.93M |
| Cash outflows from operating activities | -10.01%2.71B | -10.53%1.82B | -5.20%961.69M | 3.93%3.57B | -7.08%3.02B | -5.14%2.03B | 4.66%1.01B | -0.32%3.43B | 8.54%3.24B | 10.83%2.14B |
| Net cash flows from operating activities | -48.66%68.46M | -28.45%32.51M | -21.29%15.78M | -42.10%254.75M | 1.24%133.34M | -47.97%45.44M | -29.16%20.05M | 66.27%439.99M | 9.48%131.71M | 14.64%87.33M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --25.82M | --24.09M | ---- | ---- | ---- | ---- | ---- | -71.00%2M | -71.00%2M | ---- |
| Cash received from returns on investments | 76.55%9.19M | --3.3M | ---- | 43.20%5.36M | 39.12%5.21M | ---- | ---- | 995.24%3.74M | 995.24%3.74M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 595.39%382.7K | 589.21%379.3K | -99.09%500 | -44.92%3.1M | -98.83%55.03K | -98.78%55.03K | --55.03K | 437.17%5.63M | 3,584.34%4.7M | 3,732.80%4.51M |
| Cash inflows from investing activities | 572.56%35.39M | 50,351.18%27.77M | -99.09%500 | -25.60%8.46M | -49.60%5.26M | -98.78%55.03K | --55.03K | 37.20%11.37M | 41.74%10.44M | 1,608.03%4.51M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 20.76%104.04M | 1.11%73.69M | 3.17%29.71M | 86.05%152.12M | 8.46%86.16M | 29.11%72.89M | -28.67%28.8M | -48.85%81.76M | -32.07%79.43M | -39.19%56.45M |
| Cash paid to acquire investments | --113M | --85M | --85M | ---- | ---- | ---- | ---- | --29M | --2M | --2M |
| Cash outflows from investing activities | 151.91%217.04M | 117.73%158.69M | 298.33%114.71M | 37.34%152.12M | 5.80%86.16M | 24.69%72.89M | -28.67%28.8M | -30.71%110.76M | -30.36%81.43M | -37.04%58.45M |
| Net cash flows from investing activities | -124.55%-181.65M | -79.77%-130.93M | -299.09%-114.71M | -44.53%-143.66M | -13.95%-80.9M | -35.02%-72.83M | 28.81%-28.74M | 34.42%-99.39M | 35.21%-70.99M | 41.73%-53.94M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --2.7M | --4.7M | --2M | -94.06%4.9M | ---- | ---- | ---- | --82.48M | --82.48M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --2.7M | --4.7M | --2M | --4.9M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 31.79%816.82M | 10.51%580.62M | 30.63%252.9M | 3.74%887.62M | 7.60%619.8M | 17.12%525.38M | -23.09%193.6M | 0.53%855.6M | -24.58%576.02M | -24.86%448.59M |
| Cash inflows from financing activities | 32.22%819.52M | 11.41%585.32M | 31.66%254.9M | -4.86%892.52M | -5.88%619.8M | 17.12%525.38M | -23.09%193.6M | 4.16%938.07M | -13.78%658.5M | -24.86%448.59M |
| Borrowing repayment | -5.56%690.55M | -12.07%478.1M | -49.36%160.5M | 14.07%917.5M | 33.81%731.21M | 36.76%543.71M | 37.13%316.91M | -16.90%804.3M | -25.09%546.47M | -22.91%397.57M |
| Dividend interest payment | 27.72%69.51M | 29.86%62.58M | -22.57%5.82M | 11.65%64.17M | 4.43%54.43M | 32.65%48.19M | 25.98%7.51M | 118.73%57.48M | 66.66%52.12M | 65.69%36.33M |
| Cash payments relating to other financing activities | -1.24%27.12M | 17.65%20.84M | -17.20%6.67M | -77.54%76.05M | 8.66%27.46M | -4.52%17.72M | -8.94%8.06M | 904.79%338.56M | -2.14%25.27M | 14.71%18.55M |
| Cash outflows from financing activities | -3.19%787.18M | -7.89%561.52M | -47.97%172.99M | -11.88%1.06B | 30.33%813.09M | 34.74%609.62M | 35.20%332.48M | 16.78%1.2B | -20.69%623.85M | -18.30%452.45M |
| Net cash flows from financing activities | 116.73%32.34M | 128.25%23.79M | 158.98%81.91M | 37.01%-165.2M | -657.94%-193.29M | -2,078.65%-84.24M | -2,492.42%-138.88M | -106.07%-262.27M | 251.78%34.64M | -108.96%-3.87M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -26.80%98.9K | -34.29%123.36K | 237.17%22.52K | 97.25%173.03K | 223.83%135.12K | -11.28%187.72K | -115.68%-16.42K | 126.07%87.72K | 55.57%-109.11K | 200.93%211.6K |
| Net increase in cash and cash equivalents | 42.61%-80.75M | 33.16%-74.5M | 88.48%-17M | -168.78%-53.93M | -247.73%-140.71M | -474.76%-111.45M | -2,294.35%-147.6M | 639.24%78.42M | 871.77%95.25M | 11.90%29.74M |
| Add:Begin period cash and cash equivalents | -15.65%290.74M | -15.65%290.74M | -15.65%290.74M | 29.45%344.67M | 29.45%344.67M | 29.45%344.67M | 29.45%344.67M | -5.18%266.26M | 5.33%266.26M | 5.33%266.26M |
| End period cash equivalent | 2.95%209.99M | -7.28%216.24M | 38.90%273.74M | -15.65%290.74M | -43.58%203.96M | -21.21%233.22M | -24.23%197.08M | 29.45%344.67M | 50.36%361.51M | 5.96%296M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Securities Tiantong Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Securities Tiantong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
